May 18, 2024, 12:07
Amer Zeidan: Another great project led by super star Maximilian Stahl
Amer Zeidan shared a post on X:
“Another great project led by super star Maximilian Stahl with collaborations between Dana-Farber Cancer Institute, Yale Cancer Center, Memorial Sloan Kettering Cancer Center, Rory M. Shallis, Jan Bewersdorf, Shai Shimony, and others on sequential therapy for IDH mutated AMLsm, American Journal Hematology.”
Additional information.
Source: Amer Zeidan/X
Amer Zeidan is an Associate Professor of Medicine (Hematology) at Yale University. He is also the medical director of Hematology Early Therapeutics Research, the leader of the Myeloid Malignancies DART (Disease Aligned Research Team), and the director of Continuing Medical Education (CME) at the Hematology division and chairs the Protocol Review Committee (PRC) at Yale Cancer Center. Dr. Zeidan is a well-known leukemia researcher with a special focus on targeted therapies and immunotherapy for myeloid malignancies, and a social media influencer in the field of blood cancer.
Aaron Goldberg
Amer M. Zeidan
Amer Zeidan
American Journal Hematology
Anthony Stein
Brian Ball
cancer
Dana-Farber Cancer Institute
Daniel J. DeAngelo
Donna S. Neuberg
Eva J. Schaefer
Evan C. Chen
Eytan Stein
Guido Marcucci
Guillaume Berton
Ibrahim Aldoss
Jan Philipp Bewersdorf
Jorge Ramos
Maximilian Stahl
Memorial Sloan Kettering Cancer Center
OncoDaily
Oncology
R. Coleman Lindsley
Rebecca P. Bystrom
Richard M. Stone
Rory M. Shallis
Shai Shimony
Sylvain Garciaz
Vinod Pullarkat
Yale Cancer Center
Yale University
Yiwen Liu
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 13:12
Dec 21, 2024, 13:05
Dec 21, 2024, 12:18
Dec 21, 2024, 11:52
Dec 21, 2024, 11:30
Dec 21, 2024, 11:25